Skip to main content
OpenTrials

Clinical trial condition

Osteoporosis

Explore clinical trials studying Osteoporosis. Study availability and eligibility vary by location and protocol.

1,229 public trials 104 recruiting studies
Refine in advanced search Browse all conditions

Osteoporosis trial results

Completed

A Study to Evaluate the Effects of SB-751689 or rhPTH(1-34) on Excretion of Calcium and Phosphate in Women

NCT00532077

Conditions
Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +3 more
Locations
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site Daytona Beach, Florida, United States
  • GSK Investigational Site Port Orange, Florida, United States
  • GSK Investigational Site Honolulu, Hawaii, United States
View Trial Details
Completed

Phase 3 Clinical Trial of Teriparatide in Japan

NCT00433160

Conditions
Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +3 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyōgo, Japan
View all 16 locations
View Trial Details
Completed

Prevalence of Osteoporosis in Korean Prostate Cancer Patients Who is Receiving LHRH Agonist and/or Anti-androgen Agent

NCT01025479

Conditions
Bone Diseases, Bone Diseases, Metabolic, Genital Diseases, +14 more
Locations
  • Research Site Cheonan-si, Chungcheongnam-do, South Korea
  • Research Site Gangneung-si, Gangwon-do, South Korea
  • Research Site Goyang-si, Gyeonggi-do, South Korea
  • Research Site Guri-si, Gyeonggi-do, South Korea
View all 18 locations
View Trial Details

Related conditions